Research and development in life sciences is capital intensive. Lead researchers, business managers and chief scientists need to be able to efficiently review and access available capital resources internationally.

Pacific Channel's current report - “Guide to securing international grant funding for Australasian life sciences research 2008”, provides a detailed review of grant resources available internationally for Australia and New Zealand life sciences research.

For each grant source Guide to securing international grant funding for Australasian life sciences research 2008 provides:

·         Coded profiles of each grant entity to clarify the research and development financed by each fund:

- Fundamental research e.g. molecular basis of juvenile diabetics

- Clinical trial research

- Research and technology in the farming or environmental science sector

·         Comprehensive background information on each fund including contact details

·         Value and size of the fund

·         Criteria for grant applications

·         Information to assist with applications

Extensive case studies highlighting Australasian examples of demonstrated success in receiving EU, US and Japan grant capital are provided.

To purchase Guide to Accessing EU and US Biotechnology Grant Capital 2007 for AU$249 click here.

About the Author:

Brent S. Ogilvie, a former New Zealand Consul and Trade Commissioner to New York (specialising in life sciences), is director and co-founder of Pacific Channel. As part of Pacific Channel’s seed investments Brent Ogilvie is also CEO (part-time) and director of several biotechnology start-ups in human health as well as agbiotech. He holds a BSc. (Bio.) from The University of Waikato and a Master of Business Administration (MBA) from the University of Auckland. His MBA thesis investigated the key differences between drivers of venture capital investment and philanthropic grant into biomedical ventures.  

Pacific Channel through its access to expertise and financial capital, facilitates the growth of commercially viable biotechnology companies in Australia and New Zealand: emerging global centres of agricultural, nutritional and biomedical sciences. Pacific Channel was formed as a "channel" between Australasia and the world’s largest market - the United States, acting as a conduit toward long-term, global growth and success.